World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
107
Citations
44471
World Ranking
546
National Ranking
327

Medicine

D-Index
107
Citations
44587
World Ranking
6219
National Ranking
3315

Gianpietro Dotti publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Gianpietro Dotti sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 437 publications — 85th percentile

85% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Gianpietro Dotti D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Gianpietro Dotti sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 107 D-Index — 89th percentile

89% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Gianpietro Dotti is affiliated with the University of North Carolina at Chapel Hill in the United States. Their research primarily focuses on the field of medicine, with a substantial number of publications in oncology, immunology, genetics, molecular biology, and biomedical engineering.

The main topics of Gianpietro Dotti's research work include:

  • CAR-T cell therapy research
  • Immune Cell Function and Interaction
  • Virus-based gene therapy research
  • Immunotherapy and Immune Responses
  • Viral Infectious Diseases and Gene Expression in Insects
  • Nanowire Synthesis and Applications
  • Neuroblastoma Research and Treatments

Gianpietro Dotti has contributed to several recent publications that highlight their focus on immunotherapy and cell therapy approaches. Notable papers include:

  • Overcoming on-target, off-tumour toxicity of CAR T cell therapy for solid tumours, 2022, Nature Reviews Clinical Oncology
  • Anti-CD30 CAR-T Cell Therapy in Relapsed and Refractory Hodgkin Lymphoma, 2020, Journal of Clinical Oncology
  • Inhibition of post-surgery tumour recurrence via a hydrogel releasing CAR-T cells and anti-PDL1-conjugated platelets, 2021, Nature Biomedical Engineering
  • Anti-GD2 CAR-NKT cells in patients with relapsed or refractory neuroblastoma: an interim analysis, 2020, Nature Medicine
  • Transdermal cold atmospheric plasma-mediated immune checkpoint blockade therapy, 2020, Proceedings of the National Academy of Sciences

Frequent co-authors who have collaborated with Gianpietro Dotti include:

  • Barbara Savoldo
  • Elisa Landoni
  • Natalie S. Grover
  • Jonathan S. Serody
  • Catherine Cheng

In terms of publication outlets, their work is often featured in:

  • UNC Libraries
  • Blood
  • Journal for ImmunoTherapy of Cancer
  • Nature Communications
  • Clinical Cancer Research

Best Publications

  • Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 Concerted Action: investigation of minimal residual disease in acute leukemia.

    van Dongen Jj;Macintyre Ea;Gabert Ja;Delabesse E

  • Inducible apoptosis as a safety switch for adoptive cell therapy

    Antonio Di Stasi;Siok Keen Tey;Gianpietro Dotti;Yuriko Fujita

  • Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma

    Martin A. Pule;Barbara Savoldo;G. Doug Myers;G. Doug Myers;Claudia Rossig

  • Antitumor activity and long-term fate of chimeric antigen receptor–positive T cells in patients with neuroblastoma

    Chrystal U. Louis;Chrystal U. Louis;Barbara Savoldo;Barbara Savoldo;Gianpietro Dotti;Gianpietro Dotti;Martin Pule

  • CD28 costimulation improves expansion and persistence of chimeric antigen receptor–modified T cells in lymphoma patients

    Barbara Savoldo;Carlos Almeida Ramos;Carlos Almeida Ramos;Enli Liu;Martha P. Mims

  • Human Epidermal Growth Factor Receptor 2 (HER2) –Specific Chimeric Antigen Receptor–Modified T Cells for the Immunotherapy of HER2-Positive Sarcoma

    Nabil Ahmed;Vita S. Brawley;Meenakshi Hegde;Catherine Robertson

  • In situ sprayed bioresponsive immunotherapeutic gel for post-surgical cancer treatment

    Qian Chen;Qian Chen;Chao Wang;Xudong Zhang;Guojun Chen

  • An inducible caspase 9 safety switch for T-cell therapy

    Karin C. Straathof;Martin A. Pulè;Patricia Yotnda;Gianpietro Dotti

  • HER2-Specific Chimeric Antigen Receptor–Modified Virus-Specific T Cells for Progressive Glioblastoma: A Phase 1 Dose-Escalation Trial

    Nabil Ahmed;Nabil Ahmed;Vita Brawley;Vita Brawley;Meenakshi Hegde;Meenakshi Hegde;Kevin Bielamowicz

  • Closely related T-memory stem cells correlate with in vivo expansion of CAR.CD19-T cells and are preserved by IL-7 and IL-15

    Yang Xu;Ming Zhang;Carlos A. Ramos;April Durett

  • Heparanase promotes tumor infiltration and antitumor activity of CAR-redirected T-lymphocytes

    Ignazio Caruana;Barbara Savoldo;Valentina Hoyos;Gerrit Weber

  • Cord blood NK cells engineered to express IL-15 and a CD19-targeted CAR show long-term persistence and potent antitumor activity

    Enli Liu;Yijiu Tong;Gianpietro Dotti;Hila Shaim

  • Tandem CAR T cells targeting HER2 and IL13Rα2 mitigate tumor antigen escape

    Meenakshi Hegde;Malini Mukherjee;Malini Mukherjee;Zakaria Grada;Antonella Pignata

  • Design and development of therapies using chimeric antigen receptor-expressing T cells

    Gianpietro Dotti;Stephen Gottschalk;Barbara Savoldo;Malcolm K. Brenner

  • Engineering CD19-specific T lymphocytes with interleukin-15 and a suicide gene to enhance their anti-lymphoma/leukemia effects and safety

    Valentina Hoyos;Barbara Savoldo;Barbara Savoldo;Concetta Quintarelli;Aruna Mahendravada

  • A chimeric T cell antigen receptor that augments cytokine release and supports clonal expansion of primary human T cells

    Martin A. Pulè;Karin C. Straathof;Karin C. Straathof;Gianpietro Dotti;Gianpietro Dotti;Helen E. Heslop

  • T lymphocytes coexpressing CCR4 and a chimeric antigen receptor targeting CD30 have improved homing and antitumor activity in a Hodgkin tumor model.

    Antonio Di Stasi;Biagio De Angelis;Cliona M. Rooney;Lan Zhang

  • Infusion of donor-derived CD19-redirected virus-specific T cells for B-cell malignancies relapsed after allogeneic stem cell transplant: a phase 1 study

    Conrad Russell Y. Cruz;Kenneth P. Micklethwaite;Barbara Savoldo;Carlos A. Ramos

  • In situ formed reactive oxygen species-responsive scaffold with gemcitabine and checkpoint inhibitor for combination therapy.

    Chao Wang;Jinqiang Wang;Xudong Zhang;Shuangjiang Yu

  • TanCAR: A Novel Bispecific Chimeric Antigen Receptor for Cancer Immunotherapy

    Zakaria Grada;Zakaria Grada;Meenakshi Hegde;Meenakshi Hegde;Tiara Byrd;Tiara Byrd;Donald R Shaffer;Donald R Shaffer

Frequent Co-Authors

Barbara Savoldo
Barbara Savoldo University of North Carolina at Chapel Hill
Malcolm K. Brenner
Malcolm K. Brenner Baylor College of Medicine
Helen E. Heslop
Helen E. Heslop Baylor College of Medicine
Cliona M. Rooney
Cliona M. Rooney Baylor College of Medicine
Adrian P. Gee
Adrian P. Gee Baylor College of Medicine
Catherine M. Bollard
Catherine M. Bollard George Washington University
Hao Liu
Hao Liu Indiana University
Stephen Gottschalk
Stephen Gottschalk St. Jude Children's Research Hospital
Elizabeth J. Shpall
Elizabeth J. Shpall The University of Texas MD Anderson Cancer Center
Ann M. Leen
Ann M. Leen Baylor College of Medicine

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related online degrees can open diverse career pathways in healthcare and research. Many students with non-nursing backgrounds consider programs like online nursing programs for non nurses that provide a bridge into patient care roles without prior nursing experience.

Accelerated options, such as the easiest absn to get into programs, offer a fast-track to becoming a registered nurse by building on existing academic credentials, making these programs ideal for career changers.

Those seeking quicker entry into nursing may explore the fastest and easiest lpn programs, which provide foundational practical nursing skills in a shorter timeframe, ideal for hands-on patient support roles.

For advanced practice roles, the easiest fnp program offers family nurse practitioner training accessible through flexible online formats, preparing graduates for critical responsibilities in primary care and community health.

Combining immunology knowledge with nursing credentials can enhance career opportunities in clinical research, infectious disease management, and healthcare leadership, making these pathways valuable for future professionals.

Best Scientists Citing Gianpietro Dotti

Trending Scientists

Recently Published Articles